Stock Earnings

Question 1

What are BioXcel Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), BioXcel Therapeutics Inc has a total asset of $38, Net loss of $-59

Question 2

What are the key financial ratios for BTAI?

Accepted Answer

BioXcel Therapeutics Inc's Current ratio is 0.29, has a Net margin is -2,950, sales per share of $0.78.

Question 3

How is BioXcel Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

BioXcel Therapeutics Inc largest revenue segment is Medicines, at a revenue of 2,266,000 in the most earnings release.For geography, United States is the primary market for BioXcel Therapeutics Inc, at a revenue of 2,266,000.

Question 4

Is BioXcel Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, BioXcel Therapeutics Inc has a net loss of $-59

Question 5

Does BioXcel Therapeutics Inc have any liabilities?

Accepted Answer

yes, BioXcel Therapeutics Inc has liability of 131

Question 6

How many outstanding shares for BioXcel Therapeutics Inc?

Accepted Answer

BioXcel Therapeutics Inc has a total outstanding shares of 3.1

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	2	1	0	0	0
Revenue Growth (YoY)	-100%	100%	--	--	--	--
Cost of Revenue	2	2	1	0	--	--
Gross Profit	-1	0	0	0	--	--
Selling, General & Admin	23	34	83	68	54	24
Research & Development	25	30	84	91	52	58
Operating Expenses	48	64	167	160	106	82
Other Non Operating Income (Expenses)	15	20	0	0	--	--
Pretax Income	-50	-59	-179	-165	-106	-82
Income Tax Expense	--	--	--	--	--	--
Net Income	-50	-59	-179	-165	-106	-82
Net Income Growth	-53%	-67%	8%	56%	28.99%	156%
Shares Outstanding (Diluted)	7.84	2.53	1.82	1.75	1.64	1.35
Shares Change (YoY)	212%	39%	4%	6%	22%	33%
EPS (Diluted)	-6.49	-23.51	-98.35	-94.66	-64.87	-60.63
EPS Growth	-85%	-76%	4%	46%	7%	87%
Free Cash Flow	-55	-72	-155	-135	-82	-66
Free Cash Flow Per Share	-7.01	-28.4	-85.13	-77.1	-49.74	-48.7
Gross Margin	0%	0%	0%	0%	--	--
Operating Margin	0%	-3,200%	-16,700%	0%	0%	0%
Profit Margin	0%	-2,950%	-17,900%	0%	0%	0%
Free Cash Flow Margin	0%	-3,600%	-15,500%	0%	0%	0%
EBITDA	-50	-64	-167	-159	-106	-82
EBITDA Margin	0%	-3,200%	-16,700%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-50	-64	-167	-159	-106	-82
EBIT Margin	0%	-3,200%	-16,700%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

BioXcel Therapeutics Inc (BTAI) Price

BTAI Stock Price Chart

BTAI Income

Follow-Up Questions